Eurofins Scientific SEERFSF +2.60%81 Median PS Value is $102.78 as of Jun. 24, 2026, which is 13424% above its 10-year median of 0.76. GuruFocus rates ERFSF with a GF Score™ of 81/100 and a GF Value™ of $76.00 (Fairly Valued). The stock has 6 warning signs investors should review. Among 85 Medical Diagnostics & Research companies, Eurofins Scientific SE ranks better than 61.18% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Eurofins Scientific SE's Median PS Value or its related term are showing as below:
ERFSF'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.52 Med: 0.76 Max: 1.33
Current: 0.74
During the past 13 years, the highest Price to Median PS Value of Eurofins Scientific SE was 1.33. The lowest was 0.52. And the median was 0.76.
ERFSF's Price-to-Median-PS-Value is ranked better than 61.18% of 85
companies
in the Medical Diagnostics & Research industry
Industry Median: 0.86
vs ERFSF: 0.74
Eurofins Scientific SE (OTCPK:ERFSF) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Eurofins Scientific SE's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
76.03
/
102.78
=
0.74
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eurofins Scientific SE Median PS Value Related Terms
Eurofins Scientific SE Median PS Value Historical Data
* Premium members only.
The historical data trend for Eurofins Scientific SE's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ERFSF vs TMO, DHR, IDXX: Median PS Value Comparison
For the Diagnostics & Research subindustry, Eurofins Scientific SE's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eurofins Scientific SE Price-to-Median-PS-Value vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Eurofins Scientific SE's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Eurofins Scientific SE's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 2.2597.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Eurofins Scientific SE's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $45.483.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eurofins Scientific SE (ERFSF) has a Median PS Value of $102.78 as of Jun. 24, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Eurofins Scientific SE and its competitors. This is 13424% above median its historical median of 0.76. Over the past decade, Eurofins Scientific SE's Median PS Value has ranged from 0.52 to 1.33. According to the industry distribution chart, Eurofins Scientific SE ranks #33 out of 85 companies in the Medical Diagnostics & Research industry, placing it in the top 38.8%.
Is Eurofins Scientific SE's Median PS Value too high?
Eurofins Scientific SE's current Median PS Value of $102.78 is 13424% above median its 10-year median of 0.76. Over the past 10 years, this metric has ranged from a low of 0.52 to a high of 1.33. The Medical Diagnostics & Research industry median Median PS Value is 0.86. Eurofins Scientific SE's value of $102.78 is 11851.2% above this industry median. Based on the distribution chart, Eurofins Scientific SE ranks #33 out of 85 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Eurofins Scientific SE has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Eurofins Scientific SE's Median PS Value compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Eurofins Scientific SE ranks #33 out of 85 companies for Median PS Value. This puts Eurofins Scientific SE in the upper half of its industry. The industry median Median PS Value is 0.86. Eurofins Scientific SE's value of $102.78 is 11851.2% above this benchmark. Historically, Eurofins Scientific SE's own Median PS Value has ranged from 0.52 to 1.33 over the past decade. While the company's 10-year median is 0.76 vs. the industry median of 0.86, Eurofins Scientific SE has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Diagnostics & Research company?
The median Median PS Value among Medical Diagnostics & Research companies is 0.86, based on 85 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eurofins Scientific SE's current Median PS Value of $102.78 is 11851.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Eurofins Scientific SE and its competitors. For the Medical Diagnostics & Research industry, the median Median PS Value is 0.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eurofins Scientific SE's current Median PS Value is $102.78, which is 13424% above median its own 10-year median of 0.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eurofins Scientific SE stock overvalued right now?
Based on GuruFocus' analysis, Eurofins Scientific SE (ERFSF) is currently considered Fairly Valued. The stock's GF Value™ is $76.00, compared to a current price of $76.03 — trading 0% above its estimated fair value. The current Median PS Value is $102.78, which is 13424% above median its 10-year median of 0.76 and 11851.2% above the Medical Diagnostics & Research industry median of 0.86. Eurofins Scientific SE's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Eurofins Scientific SE (ERFSF), the current Median PS Value is $102.78 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eurofins Scientific SE (ERFSF) Overvalued in 2026?
Based on GuruFocus' analysis, Eurofins Scientific SE stock appears to be overvalued.
The current stock price of $76.03 is trading 0% above its estimated GF Value™ of $76.00.
GuruFocus considers Eurofins Scientific SE to be Fairly Valued.
Key valuation signals for ERFSF:
Median PS Value: $102.78 (13424% above median its 10-year median of 0.76)
GF Value™: $76.00 vs. price of $76.03 (0% above fair value)
Industry Position: 11851.2% above the Medical Diagnostics & Research median (#33 of 85)
No single metric tells the full story. See the ERFSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 950 laboratories in 61 countries. Its revenue from Europe, North America, and the rest of the world contributes approximately 50%, 40%, and 10% of total revenue, respectively. Its areas of business activity are food, feed, and environmental testing ("life"), biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.
81GF Score
Get the complete analysis for ERFSF
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ERFSF has been successfully added to your 
